首页> 中文期刊> 《药学学报(英文版)》 >Prussian blue nanosphere-embedded in situ hydrogel for photothermal therapy by peritumoral administration

Prussian blue nanosphere-embedded in situ hydrogel for photothermal therapy by peritumoral administration

         

摘要

To establish an injectable hydrogel containing Prussian blue (PB) nanospheres for photothermal therapy against cancer,PB nanospheres were prepared by one-pot synthesis and the thermosensitive Pluronic F127 was used as the hydrogel matrix.The PB nanospheres and the hydrogel were characterized by shape,particle size,serum stability,photothermal performance upon repeated 808 nm laser irradiation,as well as the rheological features.The effect of the PB nanospheres and the hydrogel were evaluated qualitatively and quantitatively in 4T1 mouse breast cancer cells.The retention,photothermal efficacy,therapeutic effects and systemic toxicity of the hydrogel were assessed in a tumor-bearing mouse model.The PB nanospheres had a diameter of about 150nm and exhibited satisfactory serum stability,photo-heat convert ability and repeated laser exposure stability.The hydrogel encapsulation did not negatively influence the above features of the photothermal agent.The nanospherecontaining hydrogel showed a phase transition at body temperature and,as a result,a long retention time in vivo.The photothermal agent-embedded hydrogel displayed promising photothermal therapeutic effects in the tumor-bearing mouse model with little-to-no systemic toxicity after peritumoral administration.

著录项

  • 来源
    《药学学报(英文版)》 |2019年第3期|604-614|共11页
  • 作者单位

    The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510700, China;

    Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University,Guangzhou 511436, China;

    The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510700, China;

    Center of Pharmaceutical Research and Development, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China;

    Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University,Guangzhou 511436, China;

    The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510700, China;

    Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University,Guangzhou 511436, China;

    The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510700, China;

    Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University,Guangzhou 511436, China;

    Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University,Guangzhou 511436, China;

    Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University,Guangzhou 511436, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号